Neuromuscular transmission in Ca2+-free extracellular solution

2016 ◽  
Vol 10 (2) ◽  
pp. 99-108 ◽  
Author(s):  
S. N. Grishin
Keyword(s):  
Neuromuscular Transmission ◽  
Extracellular Solution

Effect of halothane on neuromuscular transmission

JAMA ◽  
1966 ◽  
Vol 197 (10) ◽  
pp. 770-774 ◽  
Author(s):  
A. J. Gissen
Keyword(s):  
Neuromuscular Transmission

Changes of neuromuscular transmission in smooth muscles of rats bladder with experimental diabetes

2014 ◽  
Vol 60 (2) ◽  
pp. 31-37
Author(s):  
IA Vladimirova ◽  
◽  
IB Filippov ◽  
ON Paduraru ◽  
ÉIa Shuba ◽  
...  
Keyword(s):  
Neuromuscular Transmission ◽  
Experimental Diabetes ◽  
Smooth Muscles

State of neuromuscular transmission in vibration disease, according to electroneuromyographic test

2020 ◽  
pp. 55-68
Author(s):  
Sergey Babanov
Keyword(s):  
Neuromuscular Transmission ◽  
System Development ◽  
Disease Type ◽  
Functional Mobility ◽  
Sensorimotor System ◽  
Muscular System ◽  
Vibration Disease ◽  
Regional Center ◽  
Occupational Disorders ◽  
Sensory Polyneuropathy

The article covers the particular features of the neuro-muscular system in vibration disease of various types and severity by electroneuromyographical tests at the Department of Occupational Disorders, Regional Center for Occupational Disorders, Samara Medical and Sanitary Unit № 5 of the Kirov Region (State Budgetary Healthcare Institution of the Samara Region). Changes in excitability and functional mobility of the sensorimotor system, development of vegetative-sensory polyneuropathy depending on the vibration disease type, severity, and the length of exposure to vibration at work are found in vibration disease patients.

scholarly journals COVID-19 in a Cohort of Patients with Congenital Myasthenic Syndrome

2021 ◽  
pp. 1-3
Author(s):  
Setareh Alabaf ◽  
Karen O'Connell ◽  
Sithara Ramdas ◽  
David Beeson ◽  
Jacqueline Palace
Keyword(s):  
High Risk ◽  
Neuromuscular Transmission ◽  
Genetic Disorders ◽  
Severe Disease ◽  
Congenital Myasthenic Syndrome ◽  
Referral Centre ◽  
History Of ◽  
Myasthenic Syndrome ◽  
The Uk ◽  
Rare Group

Congenital Myasthenic Syndrome (CMS) are a rare group of genetic disorders of neuromuscular transmission. Some subtypes of CMS can be associated with respiratory and bulbar weakness and these patients may therefore be at high risk of developing a severe disease from COVID-19. We screened 73 patients with genetically confirmed CMS who were attending the UK national referral centre for evidence of previous Severe Acute Respiratory Syndrome Corona Virus 2 infection and their clinical outcome. Of 73 patients, seven had history of confirmed COVID-19. None of the infected patients developed a severe disease, and there were no signals that CMS alone carries a high risk of severe disease from COVID-19.

Sign in / Sign up

Export Citation Format

Share Document